US$ 23.79
glp-1 small molecule agonist Synthetic secretagogues prepared by means of a three-component indole annulation strategy Figure 1 from Small Molecule
Description
Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation

Compounded and FDA-approved medications are not interchangeable

Diab Vasc

Marso et al., 2016

Semaglutide (Rybelsus) tablets [package insert]
To achieve proof of concept, we evaluated the capacity of cyclohepta[ b ]indoles to act as glucagon-like peptide-1 (GLP-1) secretagogues
